161 related articles for article (PubMed ID: 25808864)
1. Identification of Rare High-Avidity, Tumor-Reactive CD8+ T Cells by Monomeric TCR-Ligand Off-Rates Measurements on Living Cells.
Hebeisen M; Schmidt J; Guillaume P; Baumgaertner P; Speiser DE; Luescher I; Rufer N
Cancer Res; 2015 May; 75(10):1983-91. PubMed ID: 25808864
[TBL] [Abstract][Full Text] [Related]
2. Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
Gannon PO; Wieckowski S; Baumgaertner P; Hebeisen M; Allard M; Speiser DE; Rufer N
J Immunol; 2015 Jul; 195(1):356-66. PubMed ID: 26002978
[TBL] [Abstract][Full Text] [Related]
3. High Peptide Dose Vaccination Promotes the Early Selection of Tumor Antigen-Specific CD8 T-Cells of Enhanced Functional Competence.
Carretero-Iglesia L; Couturaud B; Baumgaertner P; Schmidt J; Maby-El Hajjami H; Speiser DE; Hebeisen M; Rufer N
Front Immunol; 2019; 10():3016. PubMed ID: 31969886
[TBL] [Abstract][Full Text] [Related]
4. Decreased binding of peptides-MHC class I (pMHC) multimeric complexes to CD8 affects their binding avidity for the TCR but does not significantly impact on pMHC/TCR dissociation rate.
Dutoit V; Guillaume P; Ayyoub M; Hesdorffer CS; Luescher IF; Valmori D
J Immunol; 2003 May; 170(10):5110-7. PubMed ID: 12734357
[TBL] [Abstract][Full Text] [Related]
5. The duration of TCR/pMHC interactions regulates CTL effector function and tumor-killing capacity.
Riquelme E; Carreño LJ; González PA; Kalergis AM
Eur J Immunol; 2009 Aug; 39(8):2259-69. PubMed ID: 19637198
[TBL] [Abstract][Full Text] [Related]
6. Dissecting TCR-MHC/peptide complex interactions with A2/peptide multimers incorporating tumor antigen peptide variants: crucial role of interaction kinetics on functional outcomes.
Dutoit V; Guillaume P; Cerottini JC; Romero P; Valmori D
Eur J Immunol; 2002 Nov; 32(11):3285-93. PubMed ID: 12555674
[TBL] [Abstract][Full Text] [Related]
7. Establishment of the reversible peptide-major histocompatibility complex (pMHC) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8(+) T lymphocytes.
Tischer S; Kaireit T; Figueiredo C; Hiller O; Maecker-Kolhoff B; Geyeregger R; Immenschuh S; Blasczyk R; Eiz-Vesper B
Int Immunol; 2012 Sep; 24(9):561-72. PubMed ID: 22740564
[TBL] [Abstract][Full Text] [Related]
8. Flow cytometry-based TCR-ligand Koff -rate assay for fast avidity screening of even very small antigen-specific T cell populations ex vivo.
Nauerth M; Stemberger C; Mohr F; Weißbrich B; Schiemann M; Germeroth L; Busch DH
Cytometry A; 2016 Sep; 89(9):816-25. PubMed ID: 27564267
[TBL] [Abstract][Full Text] [Related]
9. Identifying Individual T Cell Receptors of Optimal Avidity for Tumor Antigens.
Hebeisen M; Allard M; Gannon PO; Schmidt J; Speiser DE; Rufer N
Front Immunol; 2015; 6():582. PubMed ID: 26635796
[TBL] [Abstract][Full Text] [Related]
10. Overall avidity declines in TCR repertoires during latent CMV but not EBV infection.
Couturaud B; Doix B; Carretero-Iglesia L; Allard M; Pradervand S; Hebeisen M; Rufer N
Front Immunol; 2023; 14():1293090. PubMed ID: 38053994
[TBL] [Abstract][Full Text] [Related]
11. Modulation of T cell function by TCR/pMHC binding kinetics.
Carreño LJ; González PA; Kalergis AM
Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
[TBL] [Abstract][Full Text] [Related]
12. CD8 kinetically promotes ligand binding to the T-cell antigen receptor.
Gakamsky DM; Luescher IF; Pramanik A; Kopito RB; Lemonnier F; Vogel H; Rigler R; Pecht I
Biophys J; 2005 Sep; 89(3):2121-33. PubMed ID: 15980174
[TBL] [Abstract][Full Text] [Related]
13. T cell receptor binding kinetics required for T cell activation depend on the density of cognate ligand on the antigen-presenting cell.
González PA; Carreño LJ; Coombs D; Mora JE; Palmieri E; Goldstein B; Nathenson SG; Kalergis AM
Proc Natl Acad Sci U S A; 2005 Mar; 102(13):4824-9. PubMed ID: 15772168
[TBL] [Abstract][Full Text] [Related]
14. Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life.
Rubio-Godoy V; Dutoit V; Rimoldi D; Lienard D; Lejeune F; Speiser D; Guillaume P; Cerottini JC; Romero P; Valmori D
Proc Natl Acad Sci U S A; 2001 Aug; 98(18):10302-7. PubMed ID: 11517329
[TBL] [Abstract][Full Text] [Related]
15. CD8 modulation of T-cell antigen receptor-ligand interactions on living cytotoxic T lymphocytes.
Luescher IF; Vivier E; Layer A; Mahiou J; Godeau F; Malissen B; Romero P
Nature; 1995 Jan; 373(6512):353-6. PubMed ID: 7830771
[TBL] [Abstract][Full Text] [Related]
16. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers.
Yee C; Savage PA; Lee PP; Davis MM; Greenberg PD
J Immunol; 1999 Feb; 162(4):2227-34. PubMed ID: 9973498
[TBL] [Abstract][Full Text] [Related]
17. Impact of CD8-MHC class I interaction in detection and sorting efficiencies of antigen-specific T cells using MHC class I/peptide multimers: contribution of pMHC valency.
Neveu B; Echasserieau K; Hill T; Kuus-Reichel K; Houssaint E; Bonneville M; Saulquin X
Int Immunol; 2006 Jul; 18(7):1139-45. PubMed ID: 16751231
[TBL] [Abstract][Full Text] [Related]
18. A correlation between function and selected measures of T cell avidity in influenza virus-specific CD8+ T cell responses.
La Gruta NL; Doherty PC; Turner SJ
Eur J Immunol; 2006 Nov; 36(11):2951-9. PubMed ID: 17072910
[TBL] [Abstract][Full Text] [Related]
19. Spatial coordination of CD8 and TCR molecules controls antigen recognition by CD8+ T-cells.
Pecht I; Gakamsky DM
FEBS Lett; 2005 Jun; 579(15):3336-41. PubMed ID: 15913613
[TBL] [Abstract][Full Text] [Related]
20. Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognition.
Wilde S; Sommermeyer D; Leisegang M; Frankenberger B; Mosetter B; Uckert W; Schendel DJ
J Immunol; 2012 Jul; 189(2):598-605. PubMed ID: 22689880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
